GSTM1 and Thrombocytopenia: Blood tests revealed moderate normochromic normocytic anemia (Hb 8.1 g/dl), mild thrombocytopenia (121,000/μL), subtherapeutic INR (1.21), mild inflammatory syndrome (CRP 2.99 mg/dl), and a high level of N-terminal pro-brain natriuretic peptide (NTproBNP 8586 pg/mL).